At the time, she was already eating a healthy diet, and her doctor thought this medication could make it easier for her to lose weight
Price Trends Over Time 2022 (Early Compounded Tirzepatide): Limited availability Prices: $599-$899/month Few providers High demand, low supply 2023 (Market Expansion): More providers entered market Prices decreased: $449-$699/month Increased competition Better availability 2024 (Market Maturation): Significant provider expansion Prices dropped further: $349-$599/month Highly competitive market TrimRx launched at $349/month 2025-2026: Mature competitive market Stabilized pricing: $349-$699/month Clear price leaders emerging Quality and price increasingly transparent Trend: Prices declining due to competition while quality maintained
Novo is following in the footsteps of competitor Eli Lilly, which began selling its obesity drug Zepbound with telehealth companies at a lower cost last year
Key Takeaways By suppressing appetite and boosting satiety, Tirzepatide supports your commitment to a weight loss-focused diet
In the United Kingdom, its preparation, reconstitution, and administration are legally restricted to formally authorised clinical trials operating under a Clinical Trial Authorisation (CTA) issued by the MHRA